Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» peginesatide
peginesatide
Will the FDA Approve Affymax's Peginesatide?
Motley Fool
Mon, 03/26/12 - 09:23 pm
FDA
Affymax
peginesatide
anemia
Affymax rises after analyst sets 'Outperform' rating, ahead of FDA ruling on anemia drug
Yahoo/AP
Sat, 03/24/12 - 11:31 am
peginesatide
anemia
Affymax
Affymax rises on analyst view of anemia drug
Yahoo/AP
Sat, 03/3/12 - 11:09 am
Affymax
peginesatide
Epogen
anemia
US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide
Pharmabiz
Sat, 12/10/11 - 01:23 pm
Affymax
peginesatide
Takeda
chronic kidney disease
Affymax: A Soaring Biotech With Room to Run
Motley Fool
Fri, 12/9/11 - 11:43 am
Affymax
peginesatide
Affymax Rises After Winning Panel’s Backing for Anemia Drug
Bloomberg
Thu, 12/8/11 - 11:32 am
anemia
FDA
advisory panels
Affymax
peginesatide
Affymax Jumps Most in 16 Months on FDA Review of Anemia Drug
Bloomberg
Mon, 12/5/11 - 01:34 pm
Affymax
FDA
anemia
chronic kidney disease
JNJ
Amgen
peginesatide
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny
Xconomy
Fri, 11/18/11 - 11:50 am
anemia
FDA
advisory panels
Affymax
peginesatide
Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011
Yahoo/BusinessWire
Sat, 11/12/11 - 12:16 pm
peginesatide
chronic kidney disease
dialysis
Affymax
Takeda
FDA sets date to review Affymax anemia drug
Yahoo/AP
Mon, 10/24/11 - 11:36 am
FDA
Affymax
anemia
peginesatide
chronic kidney disease
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals